Sundt™ Carotid Shunt Retrospective Post Market Clinical Follow-up Study (PMCF) - Trial NCT03816202
Access comprehensive clinical trial information for NCT03816202 through Pure Global AI's free database. This phase not specified trial is sponsored by Integra LifeSciences Corporation and is currently Completed. The study focuses on Carotid Artery Stenosis. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Integra LifeSciences Corporation
Timeline & Enrollment
N/A
Apr 25, 2019
Aug 27, 2019
Primary Outcome
Evidence of Injury to the Artery or Cerebral Ischemia Secondary to Shunt Placement and Removal
Summary
The primary objective of this study is to retrospectively investigate the safety and efficacy
 of the Integra Sundt™ carotid shunt during endarterectomy procedures.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT03816202
Device Trial